Officiële publicaties TME Pharma N.V.

Aandelen

Beurs gesloten - Euronext Paris Andere beurzen 17:29:27 14-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,205 ^EUR	-5,09%		-10,87%	-10,87%

25/04	TME Pharma N.V. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
23/04	TME Pharma N.V. kondigt aan dat 33% van de patiënten die NOX-A12 krijgen in combinatie met Bevacizumab en radiotherapie twee jaar overleving bereiken in de GLORIA Fase 1/2 studie naar hersenkanker	CI

Extraordinary general shareholder meeting	16-05-22	CO
Extraordinary general shareholder meeting	16-05-22	CO
Extraordinary general shareholder meeting	16-05-22	CO
Annual Report	22-04-22	CO
Annual results	22-04-22	CO
Annual results	22-04-22	CO
Annual results	22-04-22	CO
Minutes of the general assembly	15-12-21	CO
Minutes of the general assembly	15-12-21	CO
Minutes of the general assembly	15-12-21	CO
Half-year report	22-10-21	CO
1st-half-year results	22-10-21	CO
1st-half-year results	22-10-21	CO
1st-half-year results	22-10-21	CO
Changes in management and corporate officers	24-06-21	CO
Changes in management and corporate officers	24-06-21	CO
Changes in management and corporate officers	24-06-21	CO
Changes in management and corporate officers	08-02-21	CO
Changes in management and corporate officers	08-02-21	CO
Changes in management and corporate officers	08-02-21	CO
Changes in management and corporate officers	01-02-21	CO
Changes in management and corporate officers	01-02-21	CO
Changes in management and corporate officers	01-02-21	CO
Admission of new securities	26-01-21	CO
Admission of new securities	26-01-21	CO